Literature DB >> 3154099

Effect of partial portal vein ligation on hepatic regeneration.

D Kahn1, M Kajani, Q Zeng, H S Lai, P K Eagon, L Makowka, T E Starzl, D H Van Thiel.   

Abstract

To evaluate the effect of portal hypertension and diminished portal venous blood flow to the liver on hepatic regeneration, male rats were subjected to partial portal vein ligation and subsequently to a two-thirds partial hepatectomy. The levels of ornithine decarboxylase activity at 6 h after partial hepatectomy were greater (p less than 0.001) in the rats with prior partial portal vein ligation than in those without portal hypertension. The rats with prior partial portal vein ligation also had greater (p less than 0.005) levels of thymidine kinase activity at 48 h after partial hepatectomy than did those without portal hypertension. Hepatic sex hormone receptor activity was not affected by prior partial portal vein ligation either before or after partial hepatectomy. The reductions in both estrogen and androgen receptor activity observed in the hepatic cytosol after partial hepatectomy were similar to those observed in control animals. These data indicate that animals with portal hypertension having a diminished hepatic portal blood flow have a normal capacity to regenerate hepatic mass following a hepatic resection.

Entities:  

Mesh:

Year:  1988        PMID: 3154099      PMCID: PMC3091355          DOI: 10.3109/08941938809141092

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  19 in total

1.  Liver regeneration following portacaval shunt.

Authors:  B FISHER; S H LEE; E R FISHER; E SAFFER
Journal:  Surgery       Date:  1962-07       Impact factor: 3.982

2.  Incorporation of thymidine into deoxyribonucleic acid by enzymes from rat tissues.

Authors:  F J BOLLUM; V R POTTER
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

3.  Purification and properties of thymidine kinase from regenerating rat liver.

Authors:  D E Kizer; L Holman
Journal:  Biochim Biophys Acta       Date:  1974-05-20

Review 4.  Hepatotrophic substances.

Authors:  T E Starzl; J Terblanche
Journal:  Prog Liver Dis       Date:  1979

5.  Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors.

Authors:  D Russell; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

6.  Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration.

Authors:  T E Starzl; K A Porter; C W Putnam
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

7.  Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver.

Authors:  J A McGowan; N Fausto
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857

8.  An evaluation of the respective roles of portosystemic shunting and portal hypertension in rats upon the production of gonadal dysfunction in cirrhosis.

Authors:  D H Van Thiel; J S Gavaler; C F Cobb; C J McClain
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

9.  Transhepatic changes in insulin and glucagon following partial hepatectomy in the pig.

Authors:  D Kahn; R van Hoorn-Hickman; J Terblanche; P Child
Journal:  Surg Gynecol Obstet       Date:  1984-05

10.  Insulin, glucagon and liver regeneration.

Authors:  R E Kirsch; L O Frith; A Vinik; J Terblanche
Journal:  S Afr Med J       Date:  1980-11-22
View more
  2 in total

Review 1.  Animal models of hepatotoxicity.

Authors:  Ganesh Singh Bhakuni; Onkar Bedi; Jitender Bariwal; Rahul Deshmukh; Puneet Kumar
Journal:  Inflamm Res       Date:  2015-10-01       Impact factor: 4.575

2.  Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats.

Authors:  Lakmie S Gunarathne; Peter W Angus; Chandana B Herath
Journal:  Front Physiol       Date:  2019-09-20       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.